{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:28:11Z","timestamp":1782808091501,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71874168"],"award-info":[{"award-number":["71874168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11557-3","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:25:53Z","timestamp":1758882353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to on-demand and daily oral pre-exposure prophylaxis for HIV among men who have sex with men in China: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houlin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"11557_CR1","doi-asserted-by":"publisher","first-page":"e59101","DOI":"10.2196\/59101","volume":"27","author":"B Lin","year":"2025","unstructured":"Lin B, Liu J, Li K, Zhong X. Predicting the risk of HIV infection and sexually transmitted diseases among men who have sex with men: cross-sectional study using multiple machine learning approaches. J Med Internet Res. 2025;27:e59101. https:\/\/doi.org\/10.2196\/59101.","journal-title":"J Med Internet Res"},{"issue":"1","key":"11557_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1186\/s12889-025-22499-5","volume":"25","author":"R Su","year":"2025","unstructured":"Su R, Liu Y, Shan D, Li P, Ge L, Li D. Prevalence of HIV\/syphilis co-infection among men who have sex with men in China: a systematic review and meta-analysis. BMC Public Health. 2025;25(1):1297. https:\/\/doi.org\/10.1186\/s12889-025-22499-5.","journal-title":"BMC Public Health"},{"issue":"6","key":"11557_CR3","doi-asserted-by":"publisher","first-page":"e0287627","DOI":"10.1371\/journal.pone.0287627","volume":"18","author":"JJ Dietrich","year":"2023","unstructured":"Dietrich JJ, Ahmed N, Tshabalala G, Wu M, Mulaudzi M, Hornschuh S, et al. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South africa, Uganda and Zimbabwe. PLoS One. 2023;18(6):e0287627. https:\/\/doi.org\/10.1371\/journal.pone.0287627.","journal-title":"PLoS One"},{"issue":"3","key":"11557_CR4","doi-asserted-by":"publisher","first-page":"E560","DOI":"10.9778\/cmajo.20220113","volume":"11","author":"OJ Pico-Espinosa","year":"2023","unstructured":"Pico-Espinosa OJ, Hull M, MacPherson P, Grace D, Lachowsky N, Gaspar M, et al. Reasons for not using pre-exposure prophylaxis for HIV and strategies that May facilitate uptake in Ontario and British Columbia among gay, bisexual and other men who have sex with men: a cross-sectional survey. CMAJ Open. 2023;11(3):E560\u20138. https:\/\/doi.org\/10.9778\/cmajo.20220113.","journal-title":"CMAJ Open"},{"issue":"6","key":"11557_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001191","volume":"3","author":"W Agwang","year":"2023","unstructured":"Agwang W, Nangendo J, Nabikande S, Okello T, Tusabe J, Semitala FC, et al. Factors associated with willingness to take pre-exposure prophylaxis (PrEP) among high-risk adolescent boys and young men in Masese fishing community, Uganda. PLOS Glob Public Health. 2023;3(6): e0001191. https:\/\/doi.org\/10.1371\/journal.pgph.0001191.","journal-title":"PLOS Glob Public Health"},{"key":"11557_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107874","volume":"154","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Li H, Huang Y, Zhou Z, He Z, Agins B, et al. HIV pre-exposure prophylaxis (PrEP) use among PrEP-eligible men who have sex with men: a systematic review and meta-analysis. Int J Infect Dis. 2025y;154: 107874. https:\/\/doi.org\/10.1016\/j.ijid.2025.107874.","journal-title":"Int J Infect Dis"},{"key":"11557_CR7","unstructured":"US Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV. 2012. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm312210.htm. Accessed Apr 2023."},{"key":"11557_CR8","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. 2016. https:\/\/www.who.int\/publications\/i\/item\/9789241511124. Accessed May 2023."},{"issue":"6","key":"11557_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26130","volume":"26","author":"S Diabat\u00e9","year":"2023","unstructured":"Diabat\u00e9 S, B\u00e9hanzin L, Gu\u00e9dou FA, Goma-Mats\u00e9ts\u00e9 E, Olodo M, Aza-Gnandji M, et al. Pre-exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa. J Int AIDS Soc. 2023;26(6): e26130. https:\/\/doi.org\/10.1002\/jia2.26130.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"11557_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s43058-023-00450-2","volume":"4","author":"KN Piper","year":"2023","unstructured":"Piper KN, Anderson KM, Kokubun CW, Sheth AN, Sales J. Using qualitative comparative analysis to understand the conditions that produce successful PrEP implementation in family planning clinics. Implement Sci Commun. 2023;4(1):64. https:\/\/doi.org\/10.1186\/s43058-023-00450-2.","journal-title":"Implement Sci Commun"},{"issue":"2","key":"11557_CR11","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S2352-3018(24)00300-X","volume":"12","author":"WC Irie","year":"2025","unstructured":"Irie WC, Nicol MR, Clement M, Bukusi EA, Bekker LG, Molina JM, et al. Event-driven PrEP beyond cisgender men who have sex with men. Lancet HIV. 2025;12(2):e143\u201353. https:\/\/doi.org\/10.1016\/S2352-3018(24)00300-X.","journal-title":"Lancet HIV"},{"issue":"5","key":"11557_CR12","doi-asserted-by":"publisher","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","volume":"12","author":"OM E","year":"2022","unstructured":"E OM, Marshall L, Teljeur C, Harrington P, Hayes C, Moran P, et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478. https:\/\/doi.org\/10.1136\/bmjopen-2020-048478.","journal-title":"BMJ Open"},{"key":"11557_CR13","unstructured":"World Health Organization. What\u2019s the 2\u2009+\u20091\u2009+\u20091? Eventdriven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO\u2019s recommendation on oral PrEP. 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325955\/WHO-CDS-HIV-19.8-eng.pdf?ua=1. Accessed May 2023."},{"key":"11557_CR14","doi-asserted-by":"publisher","unstructured":"Anderson PL, Garc\u00eda-Lerma JG, Heneine W. Nondaily preexposure prophylaxis for HIV prevention. Curr Opin HIV AIDS. 2016;11(1):94-101.\u00a0https:\/\/doi.org\/10.1097\/COH.0000000000000213.","DOI":"10.1097\/COH.0000000000000213"},{"issue":"5","key":"11557_CR15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/cid\/ciu916","volume":"60","author":"SM Seifert","year":"2015","unstructured":"Seifert SM, Glidden DV, Meditz AL, Castillo-Mancilla JR, Gardner EM, Predhomme JA, et al. Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men. Clin Infect Dis. 2015;60(5):804\u201310. https:\/\/doi.org\/10.1093\/cid\/ciu916.","journal-title":"Clin Infect Dis"},{"issue":"23","key":"11557_CR16","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1506273.","journal-title":"N Engl J Med"},{"key":"11557_CR17","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Chidiac C, Charreau I, et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. 2018.\u00a0https:\/\/ecom.ngo\/wp-content\/uploads\/2018\/01\/clarity_on_PrEP_SLIDES-2.pdf. Accessed May 2023."},{"issue":"4","key":"11557_CR18","first-page":"138","volume":"25","author":"SP Buchbinder","year":"2018","unstructured":"Buchbinder SP. Maximizing the benefits of HIV preexposure prophylaxis. Top Antivir Med. 2018;25(4):138\u201342.","journal-title":"Top Antivir Med"},{"issue":"7","key":"11557_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz287","volume":"6","author":"VJ Cornelisse","year":"2019","unstructured":"Cornelisse VJ, Lal L, Price B, Ryan KE, Bell C, Owen L, et al. Interest in switching to on-demand HIV pre-exposure prophylaxis (PrEP) among Australian users of daily prep: an online survey. Open Forum Infect Dis. 2019;6(7): ofz287. https:\/\/doi.org\/10.1093\/ofid\/ofz287.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"11557_CR20","doi-asserted-by":"publisher","first-page":"e25389","DOI":"10.1002\/jia2.25389","volume":"22","author":"HM Zimmermann","year":"2019","unstructured":"Zimmermann HM, Eekman SW, Achterbergh RC, van der Schim MF, Prins M, de Vries HJ, et al. Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis. J Int AIDS Soc. 2019;22(10):e25389. https:\/\/doi.org\/10.1002\/jia2.25389.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"11557_CR21","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1093\/jac\/dkz220","volume":"74","author":"M Siguier","year":"2019","unstructured":"Siguier M, Mera R, Pialoux G, Ohayon M, Cotte L, Valin N, et al. First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate\/emtricitabine. J Antimicrob Chemother. 2019;74(9):2752\u20138. https:\/\/doi.org\/10.1093\/jac\/dkz220.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"11557_CR22","doi-asserted-by":"publisher","first-page":"e25768","DOI":"10.1002\/jia2.25768","volume":"24","author":"VW Jongen","year":"2021","unstructured":"Jongen VW, Reyniers T, Ypma ZM, van der Schim MF, Davidovich U, Zimmermann HM, et al. Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men. J Int AIDS Soc. 2021;24(8):e25768. https:\/\/doi.org\/10.1002\/jia2.25768.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"11557_CR23","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/s2352-3018(19)30136-5","volume":"6","author":"E Hoornenborg","year":"2019","unstructured":"Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, van der Schim MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in amprep: 2 year results from a demonstration study. Lancet HIV. 2019;6(7):e447\u201355. https:\/\/doi.org\/10.1016\/s2352-3018(19)30136-5.","journal-title":"Lancet HIV"},{"issue":"10","key":"11557_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25407","volume":"22","author":"B Vuylsteke","year":"2019","unstructured":"Vuylsteke B, Reyniers T, De Baetselier I, N\u00f6stlinger C, Crucitti T, Buyze J, et al. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. J Int AIDS Soc. 2019;22(10): e25407. https:\/\/doi.org\/10.1002\/jia2.25407.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"11557_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3760\/cma.j.cn112338-20220831-00749","volume":"44","author":"X Pan Ling","year":"2023","unstructured":"Pan Ling X, Hui Y, Fei S, Duo Z, Dapeng W. Status and associated factors of pre-exposure prophylaxis use among men who have sex with men in 24 cities in China. Chin J Epidemiol. 2023;44(6):905\u201311. https:\/\/doi.org\/10.3760\/cma.j.cn112338-20220831-00749.","journal-title":"Chin J Epidemiol"},{"issue":"1","key":"11557_CR26","doi-asserted-by":"publisher","first-page":"e17173","DOI":"10.2196\/17173","volume":"7","author":"J Knox","year":"2021","unstructured":"Knox J, Chen YN, He Q, Liu G, Jones J, Wang X, et al. Use of geosocial networking apps and HIV risk behavior among men who have sex with men: case-crossover study. JMIR Public Health Surveill. 2021;7(1):e17173. https:\/\/doi.org\/10.2196\/17173.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"11557_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3497-7","volume":"18","author":"Y Hu","year":"2018","unstructured":"Hu Y, Zhong XN, Peng B, Zhang Y, Liang H, Dai JH, et al. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in western China. BMC Infect Dis. 2018;18(1): 575. https:\/\/doi.org\/10.1186\/s12879-018-3497-7.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"11557_CR28","doi-asserted-by":"publisher","first-page":"e0247352","DOI":"10.1371\/journal.pone.0247352","volume":"16","author":"A Belludi","year":"2021","unstructured":"Belludi A, McFall AM, Solomon SS, Celentano DD, Mehta SH, Srikrishnan AK, et al. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: results from a multi-city cross-sectional survey. PLoS One. 2021;16(2):e0247352.","journal-title":"PLoS One"},{"issue":"8","key":"11557_CR29","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1007\/s10461-024-04365-4","volume":"28","author":"C Garcia","year":"2024","unstructured":"Garcia C, Rehman N, Matos-Silva J, Deng J, Ghandour S, Huang Z, et al. Interventions to improve adherence to oral pre-exposure prophylaxis: a systematic review and network meta-analysis. AIDS Behav. 2024;28(8):2534\u201346. https:\/\/doi.org\/10.1007\/s10461-024-04365-4.","journal-title":"AIDS Behav"},{"issue":"5","key":"11557_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.13419\/j.cnki.aids.2023.05.11","volume":"29","author":"YR Zhu","year":"2023","unstructured":"Zhu YR, Tian ML, Yin WY, Zhao DC, Liu X, Xue PP, et al. The compliance of HIV pre-exposure prophylaxis uptake among MSM. Chin J AIDS STD. 2023;29(5):549\u201353. https:\/\/doi.org\/10.13419\/j.cnki.aids.2023.05.11.","journal-title":"Chin J AIDS STD"},{"issue":"7","key":"11557_CR31","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1016\/s2352-3018(21)00005-9","volume":"8","author":"C Laurent","year":"2021","unstructured":"Laurent C, Demb\u00e9l\u00e9 Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, et al. HIV pre-exposure prophylaxis for men who have sex with men in West africa: a multicountry demonstration study. Lancet HIV. 2021;8(7):e420\u20138. https:\/\/doi.org\/10.1016\/s2352-3018(21)00005-9.","journal-title":"Lancet HIV"},{"key":"11557_CR32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/rmhp.S295114","volume":"14","author":"J Liu","year":"2021","unstructured":"Liu J, Deng R, Lin B, Pan H, Gao Y, Dai J, et al. Risk management on pre-exposure prophylaxis adherence of men who have sex with multiple men: a multicenter prospective cohort study. Risk Manag Healthc Policy. 2021;14:1749\u201361. https:\/\/doi.org\/10.2147\/rmhp.S295114.","journal-title":"Risk Manag Healthc Policy"},{"issue":"5","key":"11557_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25708","volume":"24","author":"VW Jongen","year":"2021","unstructured":"Jongen VW, Hoornenborg E, van den Elshout MA, Boyd A, Zimmermann HM, Coyer L, et al. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP. J Int AIDS Soc. 2021;24(5): e25708. https:\/\/doi.org\/10.1002\/jia2.25708.","journal-title":"J Int AIDS Soc"},{"issue":"13","key":"11557_CR34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1177\/09564624211031787","volume":"32","author":"L Monteiro Spindola Marins","year":"2021","unstructured":"Monteiro Spindola Marins L, Silva Torres T, Luz PM, Moreira RI, Leite IC, Hoagland B, et al. Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study. Int J STD AIDS. 2021;32(13):1231\u201341. https:\/\/doi.org\/10.1177\/09564624211031787.","journal-title":"Int J STD AIDS"},{"issue":"5","key":"11557_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1521\/aeap.2020.32.5.416","volume":"32","author":"SZ Ching","year":"2020","unstructured":"Ching SZ, Wong LP, Said MAB, Lim SH. Meta-synthesis of qualitative research of pre-exposure prophylaxis (PrEP) adherence among men who have sex with men (MSM). AIDS Educ Prev. 2020;32(5):416\u201331. https:\/\/doi.org\/10.1521\/aeap.2020.32.5.416.","journal-title":"AIDS Educ Prev"},{"issue":"4","key":"11557_CR36","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1097\/jnc.0000000000000105","volume":"30","author":"S Maxwell","year":"2019","unstructured":"Maxwell S, Gafos M, Shahmanesh M. Pre-exposure prophylaxis use and medication adherence among men who have sex with men: a systematic review of the literature. J Assoc Nurses AIDS Care. 2019;30(4):e38-61. https:\/\/doi.org\/10.1097\/jnc.0000000000000105.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"2","key":"11557_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/09540121.2019.1623374","volume":"32","author":"T Chemnasiri","year":"2020","unstructured":"Chemnasiri T, Varangrat A, Amico KR, Chitwarakorn A, Dye BJ, Grant RM, et al. Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067\/ADAPT study. AIDS Care. 2020;32(2):249\u201354. https:\/\/doi.org\/10.1080\/09540121.2019.1623374.","journal-title":"AIDS Care"},{"issue":"6","key":"11557_CR38","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/s2352-3018(23)00079-6","volume":"10","author":"JE Haberer","year":"2023","unstructured":"Haberer JE, Mujugira A, Mayer KH. The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities. Lancet HIV. 2023;10(6):e404\u201311. https:\/\/doi.org\/10.1016\/s2352-3018(23)00079-6.","journal-title":"Lancet HIV"},{"issue":"5","key":"11557_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10461-014-0958-x","volume":"19","author":"PM Mugo","year":"2015","unstructured":"Mugo PM, Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, et al. Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya. AIDS Behav. 2015;19(5):794\u2013801. https:\/\/doi.org\/10.1007\/s10461-014-0958-x.","journal-title":"AIDS Behav"},{"issue":"1","key":"11557_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-023-00528-w","volume":"20","author":"G Zhang","year":"2023","unstructured":"Zhang G, Yang X, Kang W, Liu T, Cheng L, Qu M, et al. Pre-exposure prophylaxis uptake for high-risk men who have sex with men in China: a multi-city cross-sectional survey. AIDS Res Ther. 2023;20(1): 32. https:\/\/doi.org\/10.1186\/s12981-023-00528-w.","journal-title":"AIDS Res Ther"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11557-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:25:57Z","timestamp":1758882357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11557-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11557"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11557-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A statement to confirm that all methods were carried out in accordance with relevant guidelines and regulations. The informed consent was on the first page of the electronic questionnaire, and participants click \u201cYES\u201d to continue filling out the questionnaire, otherwise the questionnaire would be invalid. This study was approved by the Institutional Review Board (IRB) of the National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention (Approval NO. X220314673).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1166"}}